In This Article, You'll Discover Understanding how NerveFreedom's unique formulation addresses multiple aspects of ner ...

CHELMSFORD, MA, USA & NOVI, MI, USA & DÜSSELDORF, Germany & TOKYO, Japan I July 02, 2025 I Asahi Kasei Pharma has started trial drug ...

Shares of Artelo Biosciences, Inc. (ARTL) more than doubled on Monday after the company announced favorable results from its ...

Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathy Two phase 3 studies are currently underway testing riliprubart in people with CIDP as a ...

Cancer survivors often experience persistent physical symptoms long after treatment ends. Expert advice highlights holistic ...